Spotlight

Mar 01, 2024

Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare professionals

Jul 11, 2023

Amyloidosis now a hot topic in cardiac imaging due to new drug treatment

A vision toward a more holistic approach to care in hereditary ATTR amyloidosis

The Orphan Drug Act Turns 40: NORD Celebrates Its Impact on Rare Diseases

Health System First in Nation to Offer Treatment for Hereditary Amyloidosis

Stem Cell Transplantation Produces Prolonged Survival With Improved Safety in Patients With AL Amyloidosis

Alnylam Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran

Gene Editing Offers Hope for Progressive Cardiomyopathy Due to Amyloidosis

Veterans and AL Amyloidosis

AL Amyloidosis and Agent Orange Veterans who develop AL amyloidosis and were exposed to Agent Orange or other herbicides during military service do not have to…

The Coverage Battle Continues for Veterans With Transthyretin Amyloidosis

The Veterans Health Administration exists to integrate health care services for those who served in the U.S. Armed Forces. Yet for many veterans, getting access to…

Subscribe to